Joseph E McClellan

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 2

Top Topics

Drug Administration

Top Venues

Therapeutic advances in chronic disease

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph E McClellan, Sesselja Ómarsdóttir, Nivedita Roy, Verena Berger, Cecilia Michel, Fausto Berti
The totality of evidence approach in the development of AVT02 (adalimumab), a biosimilar to Humira. Therapeutic advances in chronic disease 15 (2024)
Joseph E McClellan, Sesselja Ómarsdóttir, Nivedita Roy, Verena Berger, Cecilia Michel, Fausto Berti
The totality of evidence approach in the development of AVT02 (adalimumab), a biosimilar to Humira. Therapeutic advances in chronic disease 15 (2024)